In a multicenter ( 18 centers ) randomized double blind controlled trial with three arms , 170 patients were allocated to receive active rTMS combined with active venlafaxine ( n = 55 ) , active rTMS combined with placebo venlafaxine ( n = 60 ) or sham rTMS combined with active venlafaxine ( n = 55 ) .